- Published at
- by rttnews.com
positive
positive
Stock Alert: Aptorum Up 30% On Clearance To Initiate Phase 1 Trial Of ALS-4 In Canada
Shares of Aptorum Group Ltd. (APM) jumped over 30% on Wednesday morning after the company received clearance from Canada health regulator to commence a phase 1 trial of ALS-4 for infections caused by staphylococcus aureus.